Cargando…
Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study
BACKGROUND AND AIMS: The efficacy and safety of systemic atezolizumab and bevacizumab (atezo/bev) in treatment of patients with unresectable hepatocellular carcinoma (HCC) have been demonstrated. However, the efficacy of this treatment in patients with HCC and extrahepatic portal vein tumor thrombus...
Autores principales: | Wang, Kang, Xiang, Yan-Jun, Yu, Hong-Ming, Cheng, Yu-Qiang, Liu, Zong-Han, Zhong, Jing-Ya, Feng, Shuang, Ni, Qian-Zhi, Zhu, Hong-Fei, Pan, Wei-Wei, Li, Jing-Jing, Liang, Chao, Zhou, Hong-Kun, Meng, Yan, Lau, Wan Yee, Cheng, Shu-Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978499/ https://www.ncbi.nlm.nih.gov/pubmed/36875125 http://dx.doi.org/10.3389/fimmu.2023.1107542 |
Ejemplares similares
-
Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol
por: Wang, Kang, et al.
Publicado: (2022) -
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study
por: Wang, Kang, et al.
Publicado: (2023) -
Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma
por: Sun, Ju-Xian, et al.
Publicado: (2016) -
Significant response to atezolizumab plus bevacizumab treatment in unresectable hepatocellular carcinoma with major portal vein tumor thrombus: a case report
por: Komatsu, Shohei, et al.
Publicado: (2021) -
Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report
por: Hidaka, Yoshifumi, et al.
Publicado: (2022)